Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 22:06 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Ursodeoxycholic Acid vs Metformin in Gestational Diabetes Mellitus
NCT04407650 · King's College London · PHASE4 · terminated · last registry update 2026-10-28 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “CTIMP randomised part of the study was halted early due to difficulty to recruit sufficient participants.” | – | Registry record, King's College London |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against MT-ND6 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
No results, stops or Phase 3 starts on the same target in that window.
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision